Gastrointestinal complications of cancer treatment in childhood
- Authors: Ivanova S.V.1, Kulyova S.A.1, Gumbatova E.D.1, Belogurova M.B.2
 - 
							Affiliations: 
							
- N. N. Petrov Oncology Research Institute
 - St. Petersburg State Pediatric Medical University
 
 - Issue: Vol 6, No 4 (2015)
 - Pages: 56-61
 - Section: Articles
 - URL: https://journals.eco-vector.com/pediatr/article/view/1369
 - DOI: https://doi.org/10.17816/PED6456-61
 - ID: 1369
 
Cite item
Abstract
Full Text
About the authors
Svetlana Viacheslavovna Ivanova
N. N. Petrov Oncology Research Institute
														Email: Kulevadoc@yandex.ru
				                					                																			                								Department of Children`s Chemotherapy and Combined Modality Therapy				                														
Svetlana Aleksandrovna Kulyova
N. N. Petrov Oncology Research Institute
														Email: Kulevadoc@yandex.ru
				                					                																			                								MD, PhD, Dr Med Sci, Professor, Head. Department of Children`s Chemotherapy and Combined Modality Therapy				                														
Elvira Dzhangirovna Gumbatova
N. N. Petrov Oncology Research Institute
														Email: Kulevadoc@yandex.ru
				                					                																			                								Resident doctor. Department of Children`s Chemotherapy and Combined Modality Therapy				                														
Margarita Borisovna Belogurova
St. Petersburg State Pediatric Medical University
														Email: Kulevadoc@yandex.ru
				                					                																			                								MD, PhD, Dr Med Sci, Professor, Head. Department of Oncology, Pediatric oncology and Radiation therapy				                														
References
- Barnard J. A., Marshall G. S., Neblett W. W. Noncirrhotic portal fibrosis after Wilms’ tumor therapy. Gastroenterol. 1986; 90: 1054-6.
 - Barrett J. S., Patel D., Dombrowsky E. Risk Assessment of Drug Interaction Potential and Concomitant Dosing Pattern on Targeted Toxicities in Pediatric Cancer Patients. AAPS J. 2013; 15: 775-86.
 - Bottiglieri T. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside - molecular basis of a pleiotrophic molecule. Am. J. Clin. Nutr. 2002; 76: 1151-7.
 - DeLeve L. D., Shulman H. M., McDonald G. B. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 2002; 22: 27-41.
 - European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J. Hepatol. 2009; 51: 237-67.
 - Feld J. J., Modi A. A., El-Diwany R. S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders. Gastroenter. 2011; 140: 830-9.
 - Friedel H. A., Goa K. L., Benfield P. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs. 1989; 38: 389-416.
 - Halonen P., Mattila J., Mäkipernaa A. Erythrocyte concentrations of metabolites or cumulative doses of 6-mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia. Pediatr. Blood Cancer. 2006; 46: 762-6.
 - Harb A. H., Abou Fadel C., Sharara A. I. Radiation enteritis. Curr. Gastroenterol. rep. 2014; 16: 383.
 - Jirtle R. L., Anscher M. S., Alati T. Radiation sensitivity of the liver Adv. Radiat. Biol. 1990; 14: 269-311.
 - Locasciulli A., Testa M., Valsecchi M. G. Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. Blood. 1997; 90: 3799-805.
 - Maor Y, Malnick S. Liver Injury Induced by Anticancer Chemotherapy and Radiation Therapy. Intern. J. Hepatol. 2013; 815105.
 - McIntosh S., Davidson D. L., O’Brien R. T. Methotrexate hepatotoxicity in children with leukemia. J. Pediatr. 1977; 90: 1019-21.
 - Perry M. Chemotherapeutic agents and hepatotoxicity. Semin. Oncol. 1992; 19: 551-65.
 - Rubenstein E. B. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004; 100: 2026-46.
 - Socie G., Stone J. V., Wingard J. R. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N. Engl. J. Med. 1999; 341: 14-21.
 
Supplementary files
				
			
					
						
						
									



